Evidence map›Paper›PMID 39449193›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2025

Nanoplastics: Immune Impact, Detection, and Internalization after Human Blood Exposure by Single-Cell Mass Cytometry.

Laura Fusco, Arianna Gazzi, Linda Giro, Roman B Schefer, Sènan Mickael D'Almeida, Roberta Cagliani, Martina Zoccheddu, Recep Uyar, Ömur Besbinar, Doğantan Çelik and 4 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Biological Effects of Micro-/Nano-Plastics in Macrophages.Nanomaterials (Basel, Switzerland) · 2025
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Laura FuscoImmuneNano-lab, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.
Arianna GazziImmuneNano-lab, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.
Linda GiroImmuneNano-lab, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.
Roman B ScheferDepartment of Environmental Systems Science, ETH Zürich, Zürich, 8092, Switzerland.
Sènan Mickael D'AlmeidaFlow Cytometry Core Facility, School of Life Sciences, EPFL, Lausanne, 1015, Switzerland.
Roberta CaglianiImmuneNano-lab, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.
Martina ZocchedduImmunology Center of Georgia, Augusta University, Augusta, 30912, United States.
Recep UyarStem Cell Institute, Ankara University, Ankara, 06100, Turkey.
Ömur BesbinarStem Cell Institute, Ankara University, Ankara, 06100, Turkey.
Doğantan ÇelikStem Cell Institute, Ankara University, Ankara, 06100, Turkey.
Acelya YilmazerStem Cell Institute, Ankara University, Ankara, 06100, Turkey.
Denise M MitranoDepartment of Environmental Systems Science, ETH Zürich, Zürich, 8092, Switzerland.
Marco OrecchioniImmunology Center of Georgia, Augusta University, Augusta, 30912, United States.
Lucia Gemma DeloguImmuneNano-lab, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.ORCID https://orcid.org/0000-0002-2329-7260

Funding

Dipartimento di Biologia, Università degli Studi di Padova STARS Consolidator Grant (DETECTION)Erasmus+ 2022-1-TR01-KA-VET-000088373H2020 Marie Skłodowska-Curie Actions 101029140HORIZON EUROPE Marie Sklodowska-Curie Actions 101086184Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PCEFP2_186856the European Union's Horizon 2020 Research and Innovation Programme under Marie Sklodowska-Curie
6 · The paper itself

Abstract

The increasing exposure to nanoplastics (NPs) raises significant concerns for human health, primarily due to their potential bioaccumulative properties. While NPs have recently been detected in human blood, their interactions with specific immune cell subtypes and their impact on immune regulation remain unclear. In this proof-of-concept study, model palladium-doped polystyrene NPs (PS-Pd NPs) are utilized to enable single-cell mass cytometry (CyTOF) detection. The size-dependent impact of carboxylate polystyrene NPs (50-200 nm) is investigated across 15 primary immune cell subpopulations using CyTOF. By taking advantage of Pd-doping for detecting PS-Pd NPs, this work evaluates their impact on human immune-cells at the single-cell level following blood exposure. This work traces PS-Pd NPs in 37 primary immune-cell subpopulations from human blood, quantifying the palladium atom count per cell by CyTOF while simultaneously assessing the impact of PS-Pd NPs on cell viability, functionality, and uptake. These results demonstrate that NPs can interact with, interfere with, and translocate into several immune cell subpopulations after exposure. In vivo distribution experiments in mice further confirmed their accumulation in immune cells within the liver, blood, and spleen, particularly in monocytes, macrophages, and dendritic cells. These findings provide valuable insights into the impact of NPs on human health.

Indexed as

MicroplasticsNanoparticlesSingle-Cell AnalysisAnimalsCell SurvivalDendritic CellsFlow CytometryHumansMicePalladiumPolystyrenesMicroplasticsPalladiumPolystyrenesbiocompatibilityblood exposureCyTOFimmune cellspollutionsafety

Identifiers

PMID39449193
PMCPMC11938024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.